Breakthrough research with the ability to predict and prevent adverse drug responses within prescription medicine, and provide greater insight into the cause of neurodegenerative illnesses such as Parkinson’s disease and Alzheimer’s disease, are just two of six research projects Microsoft Research today announced it will support through its Computational Challenges of Genome Wide Association Studies (GWAS) program.
The supported projects were selected from 40 proposals submitted from 39 academic institutions worldwide. Microsoft Research’s goal with funding computational challenges associated with GWAS research is to aid researchers in the correlation of genetic patterns with patients’ responses to drugs, diseases, aging or the expression of genetic disorders. The ultimate goal is to enable lifesaving research through the use of technology.
|